A Thorough Pelvic Lymph Node Dissection in Presence of Positive Margins Associated With Better Clinical Outcomes in Radical Cystectomy Patients

Daniel Canter(Ochsner Medical Center), S. Bruce Malkowicz(University of Pennsylvania), John Tomaszewski(Hospital of the University of Pennsylvania), Keith VanArsdalen(University of Pennsylvania), Seema S. Sonnad(University of Pennsylvania), Thomas J. Guzzo(Hospital of the University of Pennsylvania), Matthew J. Resnick(Vanderbilt University Medical Center), Meredith Bergey(Brandeis University)
Urology
April 16, 2009
10.1016/j.urology.2009.01.024
Cited by 12

Related Papers

Long-Term Functional Outcomes after Treatment for Localized Prostate Cancer
|New England Journal of Medicine|2013|975
Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes
|European Urology|2015|688
Intravesical nadofaragene firadenovec gene therapy for BCG-unresponsive non-muscle-invasive bladder cancer: a single-arm, open-label, repeat-dose clinical trial
|The Lancet Oncology|2020|459
Association Between Radiation Therapy, Surgery, or Observation for Localized Prostate Cancer and Patient-Reported Outcomes After 3 Years
|JAMA|2017|349
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I
|The Journal of Urology|2020|268